<DOC>
	<DOCNO>NCT01676558</DOCNO>
	<brief_summary>Diffuse large B cell lymphoma ( DLBCL ) common type non-Hodgkin lymphoma Korea . Although standard therapy , call ' R-CHOP ' , many obstacle use aggressive cytotoxic chemotherapeutic agent old age , poor performance status , refractoriness , relapse disease still remain . So investigate efficacy radioimmunotherapy use 131I-rituximab refractory relapse patient DLBCL .</brief_summary>
	<brief_title>A Phase II Study 131I-rituximab Relapsed/Refractory Diffuse Large B Cell Lymphoma ( DLBCL )</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<criteria>Histologically confirm diffuse large B cell lymphoma Elderly ( &gt; 65 year ) medically ineligible standard cytotoxic chemotherapy due poor performance status , relapse refractory patient Eastern Cooperative Oncology Group performance status ≤ 2 , age≥ 20 year Relapsed refractory autologous hematopoietic stem cell transplantation ( autoHSCT ) young patient good performance status indicate high dose chemotherapy autoHSCT More one measurable lesion More 2cm sized lesion conventional CT scan , More 1cm sized lesion spiral CT contrastenhanced PET/CT Adequate renal function ( serum creatinine ≤ 2.0 mg/dl Ccr ≥ 60 ml/min ) Adequate hepatic function ( serum bilirubin ≤ 2.0 mg/dl , AST/ALT ≤ 3 upper normal limit ) Adequate bone marrow reservoir ( ANC ≥1,500/㎕ , platelet count≥ 75,000/㎕ ) patient agree purpose intention clinical trial recent ( &lt; 5 year ) history malignancy unrecovered disease ( appropriately treat skin cancer uterine cervix carcinoma situ exclude ) hemodynamically unstable due recent ( &lt; 12 month ) history severe heart disease myocardial infarction acute complication severe lung metabolic disease Combined severe neurological psychiatric disease Unrecovered infection medical disease Recent ( &lt; 30 day ) history enrollment clinical trial Pregnant breastfeed woman woman childbearing potential men employ adequate contraception least 1 year Previous history drug allergy content 131Irituximab Infection ( sepsis , pneumonia , viral infection , etc ) ( inactivate hepatitis B carrier enrol ) Young patient good performance status indicate autologous hematopoietic stem cell transplantation irrespective failure 1st line chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>diffuse large B cell lymphoma</keyword>
	<keyword>radioimmunotherapy</keyword>
	<keyword>131I-rituximab</keyword>
</DOC>